An update from Edesa Biotech (EDSA) is now available.
Edesa Biotech, Inc. shareholders have given the green light to a key amendment that boosts the company’s 2019 Equity Incentive Compensation Plan by an additional 67,000 shares. Alongside this, they’ve elected seven directors to the board and endorsed executive compensation plans during the 2024 annual meeting. In a strong show of confidence, shareholders also appointed MNP LLP as the independent auditors for the upcoming fiscal year.
For an in-depth examination of EDSA stock, go to TipRanks’ Stock Analysis page.
